Thomas H. Kean
Thomas H. Kean (R-NJ) sold $15K-$50K of $SYK (Stryker Corporation Common Stock (SYK) [ST]) on Feb 26, 2025, part of 5 transactions in this filing (2 buys, 3 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsRep. Thomas H. Kean bought $1,001 - $15,000 in $MDLZ on Feb 7, 2025 — 70 days before the Dietary Guidelines Reform Act of 2025 (HR2326) was introduced, which aims to stabilize the regulatory environment for food manufacturers.
Rep. Thomas H. Kean bought $1,001 - $15,000 in $MDLZ on Feb 7, 2025 — 70 days before the Food Secure Strikers Act of 2025 (HR2357) was introduced, which could increase purchasing power for food products.
Rep. Thomas H. Kean bought $1,001 - $15,000 in $AMZN on Feb 26, 2025 — 84 days before HR67, 'Modernizing Retrospective Regulatory Review,' was introduced, which mandates federal agencies to adopt AI and data management, potentially benefiting tech companies.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $AMZN | Amazon.com, Inc. - Common Stock (AMZN) [ST] | $1K-$15K | $214.35 | — | — | Feb 26, 2025 |
| BUY | $MDLZ | Mondelez International, Inc. - Class A Common Stock (MDLZ) [ST] | $1K-$15K | $58.45 | — | — | Feb 7, 2025 |
| PARTIAL SELL | $SYK | Stryker Corporation Common Stock (SYK) [ST] | $15K-$50K | $391.74 | — | — | Feb 26, 2025 |
| SELL | $MAGN | Magnera Corporation Common Stock (MAGN) [ST] | $1K-$15K | $22.81 | — | — | Feb 12, 2025 |
| SELL | $PRNDY | PERNOD RICARD S A SP/ADR (PRNDY) [ST] | $1K-$15K | $20.76 | — | — | Feb 7, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Restroom Access Act of 2025
HR3299 (Restroom Access Act) introduces a low-probability compliance mandate for retail establishments. Dollar stores ($DG, $DLTR) face the highest proportionally incremental costs due to thin staffing and margins, but the bill's early-stage status, single-party sponsorship, and no enacted status mean near-zero current market impact. Recent 7-day price declines in DG (-4.39%) and DLTR (-6.13%) are unrelated to this legislation.
Uyghur Policy Act of 2025
The Uyghur Policy Act of 2025 (S.1542) is an early-stage bill referred to committee, introducing mandatory supply chain scrutiny for Xinjiang-linked goods. No market impact is expected at this point given the procedural status. Walmart's stock trades at $130.64, near its 52-week high of $134.69, with a 7-day gain of 0.55% and 30-day gain of 5.12%, reflecting no material reaction to the bill's introduction.
Seniors’ Access to Critical Medications Act of 2025
HR 2484 (Seniors' Access to Critical Medications Act) creates a 2026-2030 Stark law exception allowing physicians to dispense Part D drugs directly. This structurally diverts prescription volume from retail pharmacy chains and PBM networks. CVS and Cigna face direct, measurable revenue erosion; UnitedHealth faces a mixed impact due to its owned physician practices potentially capturing dispensing revenue.
Child and Dependent Care Tax Credit Enhancement Act of 2025
HR2994 is a bill to enhance and make partially refundable the Child and Dependent Care Tax Credit. It has been referred to the House Committee on Ways and Means with no further action. At this procedural stage, there is zero near-term market impact for any publicly traded company. Real market data shows Walmart at $128.01 (7-day -3.04%) and Target at $127.87 (7-day -1.77%) driven by other factors.
No Funds for Forced Labor Act
The No Funds for Forced Labor Act (S1685) is an early-stage bill in the 119th Congress that directs the U.S. Treasury to oppose World Bank loans for projects using forced labor, specifically targeting Xinjiang. It carries zero funding and is at an early legislative stage—referred to committee with only one cosponsor. Near-term market impact is negligible; incremental compliance risk exists for AAPL, AMZN, and TSLA, but no material financial consequences are expected unless the bill advances significantly.
Food Secure Strikers Act of 2025
HR 2357, the Food Secure Strikers Act of 2025, is an early-stage bill with no near-term market impact. It has been referred to subcommittee, has no floor schedule, no companion bill passage in the Senate, and no authorized funding. Walmart and Kroger face negligible SNAP volume upside from this bill in its current state. The market data shows both stocks trading near their 52-week highs with positive 7-day and 30-day momentum unrelated to this legislation.
Modernizing Retrospective Regulatory Review
HR67 mandates federal agencies adopt AI-driven regulatory review tools, creating a new procurement category that benefits established FedRAMP-authorized cloud providers. The bill is pure authorization with no direct appropriations, but structural adoption requirements generate recurring revenue for $ORCL, $IBM, and $MSFT. Partner AI providers (e.g., Palantir, C3.ai) are secondary beneficiaries with lower confidence.
Access Technology Affordability Act of 2025
S. 1918 is an early-stage, low-probability bill proposing a refundable tax credit for blind individuals purchasing access technology. It creates no direct revenue stream for any public company and has negligible near-term market impact.
Streamlining Federal Cybersecurity Regulations Act of 2025
S.1875 is an early-stage procedural bill to create an interagency committee for harmonizing federal cybersecurity regulations. It contains no funding, no mandates, and no procurement directives. Near-term market impact is negligible.
Dietary Guidelines Reform Act of 2025
The Dietary Guidelines Reform Act of 2025 (HR2326) extends the federal dietary guideline update cycle from 5 to 10 years, providing direct regulatory relief to large packaged food and beverage manufacturers by halving mandatory reformulation frequency. The bill is early-stage (referred to subcommittee) with bipartisan cosponsors and an identical Senate companion, indicating moderate passage potential. Real market data shows consumer staples stocks have rallied 0.43% to 6.51% over the past 7 days, with $MDLZ leading at +6.51%.
Other Filings by Thomas H. Kean
Free — no credit card
Get the next Kean trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.